Wenru Su

6.9k citations
137 papers · 4.6k indexed · 2 hit papers · h-index 34
Topics
Ocular Diseases and Behçet’s Syndrome (43 papers)Systemic Lupus Erythematosus Research (28 papers)Corneal Surgery and Treatments (17 papers)
Partner nations
ChinaUnited StatesFrance

In The Last Decade

Wenru Su

128 papers receiving 4.6k citations

Hit Papers

Immune cell profiling of COVID-...201020262015202020202010100200300400500

Peers

Wenru Su
Comparison fields: 5 of 131
  • Molecular Biology 1.6k
  • Immunology 1.3k
  • Genetics 870
  • Ophthalmology 639
  • Cancer Research 560
Replace Riichiro Abe with:
Riichiro Abe Japan
Andréas Schäffler Germany
Marco Marchisio Italy
Ewa Paleolog United Kingdom
Tzafra Cohen Israel
Masahiko Mihara Japan
Naoki Yamamoto Japan
Sadanand Fulzele United States
Motokuni Aoki Japan
Sandip M. Kanse Germany
Wenru Su relative to Riichiro Abe Japan Riichiro Abe's profile →
Citations per field
00.5×4.3×
Riichiro Abe · 1×
Citations per year

Countries citing papers authored by Wenru Su

Since Specialization
Citations

This map shows the geographic impact of Wenru Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenru Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenru Su more than expected).

Fields of papers citing papers by Wenru Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenru Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenru Su. The network helps show where Wenru Su may publish in the future.

Co-authorship network of co-authors of Wenru Su

This figure shows the co-authorship network connecting the top 25 collaborators of Wenru Su. A scholar is included among the top collaborators of Wenru Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenru Su. Wenru Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 27
4 26
5 2
6 4
7 3
8 1
9 6
10 2
11 5
12 13
13 8
14 17
15 12
16 6
17 25
18 212
19 86
20 149

About Wenru Su

Wenru Su is a scholar working on Ophthalmology, Immunology and Rheumatology, having authored 137 papers that have together received 4.6k indexed citations. Recurring topics across this work include Ocular Diseases and Behçet’s Syndrome (43 papers), Systemic Lupus Erythematosus Research (28 papers) and Corneal Surgery and Treatments (17 papers). The work is most often cited by research in Genetics (870 citations), Ophthalmology (639 citations) and Immunology (1.3k citations). Wenru Su has collaborated with scholars based in China, United States and France. Frequent co-authors include Yehong Zhuo, Xiuxing Liu, Song Guo Zheng, Lihui Xie, Peixing Wan, Anh D. Lê, Shihong Shi, Andrew L. Nguyen, Zhaohao Huang and Nan Jiang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026